Metraipolis › archive › dc_a3d486d8a6a6
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41339490
- DOI
- 10.1038/s41409-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:52:32.774Z
- SHA-256 of the archived text
d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8- Stable URL of this page
https://metraipolis.com/documento/dc_a3d486d8a6a6
How to cite
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490 — Europe PMC (en), https://europepmc.org/article/MED/41339490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3d486d8a6a6 (Metraipolis archive dc_a3d486d8a6a6, sha256 d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8)
BibTeX
@misc{dca3d486d8a6a6,
title = {Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41339490},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3d486d8a6a6; sha256 d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41339490. Agents can read the archived copy with the MCP tool read_document.